PMVP icon

PMV Pharmaceuticals
PMVP

Overview Fund Activity

115 hedge funds and large institutions have $470M invested in PMV Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
1.86%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
35
Reduced
39
Closed
16
Calls
$1.88M
Puts
$727K
Net Calls
+$1.15M
Net Calls Change
+$961K

Top Buyers

1
Verition Fund Management
1
Verition Fund Management
Connecticut
$6.71M
2
Bank of America
2
Bank of America
North Carolina
$8.83M
3
Citadel Advisors
3
Citadel Advisors
Florida
$12M
4
UBS Group
4
UBS Group
Switzerland
$2.47M
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.01M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$6.78K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$24M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$35.6M
5
State Street
5
State Street
Massachusetts
$28.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
PHS
26
PFM Health Sciences
California
$2.9M -$4.54M -521,448 -61%
BBA
27
Baker Bros. Advisors
New York
$2.8M – – –
Northern Trust
28
Northern Trust
Illinois
$2.79M +$36.7K +4,215 +1%
UBS Group
29
UBS Group
Switzerland
$2.47M +$1.43M +164,543 +137%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.3M -$214K -24,546 -8%
MPAM
31
Monarch Partners Asset Management
Massachusetts
$2.29M +$462K +53,079 +25%
Voloridge Investment Management
32
Voloridge Investment Management
Florida
$2.2M +$159K +18,266 +8%
Charles Schwab
33
Charles Schwab
California
$2.19M +$30.3K +3,483 +1%
UBS AM
34
UBS AM
Illinois
$1.65M +$104K +11,901 +7%
SFM
35
Sphera Funds Management
Israel
$1.63M – – –
Barclays
36
Barclays
United Kingdom
$1.41M -$274K -31,552 -16%
HF
37
HRT Financial
New York
$1.35M +$776K +89,206 +135%
ACP
38
Acuta Capital Partners
California
$1.34M -$252 -29 -0%
EW
39
Evoke Wealth
California
$1.16M – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$1.15M +$952K +109,387 +473%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.07M +$3.01K +346 +0.3%
Citigroup
42
Citigroup
New York
$1.01M -$1.28M -146,864 -56%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.01M +$1.01M +115,689 New
Nuveen Asset Management
44
Nuveen Asset Management
Illinois
$859K -$154K -17,714 -15%
Ameriprise
45
Ameriprise
Minnesota
$699K -$44 -5 -0%
CSS
46
Cubist Systematic Strategies
Connecticut
$697K -$852K -97,949 -55%
Millennium Management
47
Millennium Management
New York
$640K -$757K -86,959 -54%
Jane Street
48
Jane Street
New York
$631K +$423K +48,593 +203%
PP
49
PDT Partners
New York
$577K +$413K +47,470 +252%
Marshall Wace
50
Marshall Wace
United Kingdom
$576K +$183K +21,000 +46%
1
2
3 4 5